| Edição |
Título |
Arquivo |
| Nº 4 (2016) |
Metabolic therapy in chronic heart failure |
|
|
Cheltsov V., Martynov A., Gushchina Y., Illarionova T., Korovyakova E.
|
| Volume 11, Nº 6 (2025) |
Metabolic-associated fatty liver disease: difficulties in diagnostics and ways to overcome them |
|
|
Minosyan I., Tarasova O., Kokorin V.
|
| Nº 3 (2018) |
Metabolically healthy obesity - focus on endothelium and inflammation |
|
|
Shul'kina S., Smirnova E.
|
| Volume 10, Nº 5 (2024) |
Metabolic markers of cerebrovascular pathology |
|
|
Tanashyan M., Antonova K., Spryshkov N., Panina A.
|
| Nº 5 (2018) |
Metabolic disorders in case of androgen deprivation: the role of endocrinologist in the management of the case |
|
|
Demidova T., Gritzkevitch E., Mishugin S.
|
| Nº S1 (2022) |
Metabolicheskie parametry v doklinicheskoy diagnostike sarkopenii u lits srednego vozrasta |
|
|
Khoroshunova E., Samoylova Y., Matveeva M., Mosienko I., Yun V., Trifonova E., Zakharchuk P., Vachadze T., Shuliko L., Galyukova D., Mutalimi V.
|
| Nº 3 (2016) |
METABOLIC SYNDROME IN PATIENTS WITH GOUT AND ITS IMPACT ON THE RISK OF CARDIOVASCULAR DISEASES |
|
|
Marusenko I., Polskaya I., Kulagina T., Vezikova N.
|
| Nº 1 (2017) |
Metagenomic analysis of oropharyngeal microbiota in patients with different phenotypes of chronic obstructive pulmonary disease |
|
|
Karnaushkina M., Fedosenko S., Petrov V., Malyavin A., Strutynskaya A., Cherkasova N., Ogorodova L.
|
| Volume 11, Nº 1 (2025) |
Methodological recommendations (draft). Systemic lupus erythematosus: Diagnosis, treatment, monitoring (short version) |
|
|
Popkova Т., Panafidina T., Lila A.
|
| Nº S1 (2022) |
Metody bal'neo- i fizioterapii v meditsinskoy reabilitatsii bol'nykh s zabolevaniyami sustavov, oslozhnennykh povyshennoy meteochuvstvitel'nost'yu |
|
|
Uyanaeva A., Tupitsyna Y., L'vova N., Lyamina N., Ksenofontova I.
|
| Nº 2 (2017) |
Metformin: review of current evidence and international recommendations |
|
|
Demidova T., Drozdova I.
|
| Nº 4 (2016) |
Metformin: updated guidance and pleiotropic potential |
|
|
Druk I., Ryapolova Y.
|
| Volume 8, Nº 9 (2022) |
NEUROINFLAMMATION AND THROMBOINFLAMMATION IN CEREBROVASCULAR DISEASE AND VASCULAR COGNITIVE IMPAIRMENT |
|
|
Koltsov I., Shchukin I., Chubykin V., Fidler M.
|
| Volume 9, Nº 2 (2023) |
MicroRNA-1 and microRNA-133: Small molecules of great importance in the aspect of cardiovascular diseases |
|
|
Aliyeva A., Teplova N., Butenko A., Averin E., Akhmedova M., Shikhova Y., Valiev R., Sariyev M., Kotikova I., Nikitin I.
|
| Volume 9, Nº 2 (2023) |
Mixed infection with hepatitis A and E in combination with hemorrhagic fever with renal syndrome |
|
|
Shiryaeva M., Lebedeva N., Baranov A., Agarkova A., Malinnikova E.
|
| Nº 7 (2017) |
Miofascial pulmonary syndrome: topical aspects of treatment at the phase of primary health care |
|
|
Trukhan D., Degovtsov E.
|
| Volume 8, Nº 10 (2022) |
Clinical case of mitral and tricuspid insufficiency in a patient with chronic rheumatic heart disease and arrhythmia by type of atrial fibrillation |
|
|
Kobzeva N., Kadyan E., Nerusin I., Saybel M., Oleinikova V., Appakov G.
|
| Volume 8, Nº 2 (2022) |
MULTICENTER PROSPECTIVE STUDY OF THE EFFICACY AND SAFETY OF THE COMBINED USE OF GLYCOSAMINOGLYCAN-PEPTIDE COMPLEX AND DIACEREIN IN PATIENTS WITH KNEE OSTEOARTHRITIS |
|
|
ALEKSEEVA L., LILA A., SHARAPOVA E., TASKINA E., KASHEVAROVA N., STREBKOVA E., MAZUROV V., ZONOVA E., OTTEVA E., YAKUPOVA S., VINOGRADOVA I.
|
| Nº S1 (2022) |
Mobil'noe prilozhenie dlya otsenki prognoza u bol'nykh khronicheskoy serdechnoy nedostatochnost'yu s uchetom funktsional'nogo sostoyaniya pochek |
|
|
Kamilova U., Masharipova D., Tagaeva D., Abdullaeva C., Beknazarova S., Ikramova F.
|
| Volume 7, Nº 7 (2021) |
Models of risk determination of cancer-associated thromboses |
|
|
Tarasova L., Dimitrieva O., Dolgov I., Elmurzayeva A.
|
| Nº 6 (2017) |
Modelling of parameters lipid a spectrum depending on age and size of an index of weight of a body at patients with clinical forms of ischemic illness of heart |
|
|
Fishman B., Khorochevskaya A., Zurabov V., Savolyuk A., Zhbanova N., Butrimova S., Prozorova I., Shamiladze D., Lole O.
|
| Volume 9, Nº 8 (2023) |
Gut microbiome modulation and cardiovascular risks: mechanisms of formation and correction |
|
|
Livzan M., Bikbavova G., Safiulina T., Loginova E.
|
| Nº S1 (2022) |
Mozhno li dietoy regulirovat' autofagiyu u cheloveka |
|
|
Tkhakushinov I.
|
| Nº 3 (2016) |
COULD WE IDENTIFY PRIMARY HEADACHE AS GLUTAMATE? |
|
|
Drobizhev M., Fedotova A., Kikta S.
|
| Nº 7 (2017) |
If it is possible to prevent metabolic remodelling possibilities of trimetazidine use |
|
|
Cheltzov V.
|
| Nº S1 (2022) |
Mozhno li schitat' povyshennye pokazateli okruzhnosti talii i okruzhnosti beder, sootnosheniya okruzhnosti talii k okruzhnosti beder, insulinopodobnogo faktora rosta-1 prediktorami follikulyarnoy adenomy shchitovidnoy zhelezy? |
|
|
Khalimova A., Kvitkova L.
|
| Nº S1 (2022) |
Molekulyarno-geneticheskie prediktory razvitiya i progressirovaniya antratsiklin-indutsirovannoy kardiotoksichnosti |
|
|
Kop'eva K.
|
| Nº 5 (2017) |
Molecular mechanisms of action of Laennec against development of metabolic syndrome and obesity |
|
|
Gromova O., Torshin I., Zgoda V., Tomilova I.
|
| Nº 4 (2015) |
MOLECULAR MECHANISMS OF BODY WEIGHT REGULATION AS TARGETS FOR PATHOGENETIC THERAPY OF OBESITY |
|
|
Romantsova T.
|
| Nº 7-8 (2018) |
Monitoring of the quality of thrombolytic therapy in case of acute coronary syndrome at pre-hospital stage |
|
|
Khusainova D., Kholkin I., Sokolova L.
|
| Nº S1 (2022) |
Monitoring rannikh narusheniy obmena kholesterina |
|
|
Pavlova V., Boyko E.
|
| Nº S1 (2022) |
Muzhchiny molodogo vozrasta s infarktom miokarda i fenomenom zamedlennogo koronarnogo krovotoka: god posle indeksnogo sobytiya |
|
|
Tkachenko V., Karpunina N.
|
| Volume 10, Nº 6 (2024) |
Mucoactive drugs in the treatment of patients with acute and chronic respiratory pathology |
|
|
Prozorova G., Budnevsky A., Chernik T.
|
| Volume 8, Nº 3 (2022) |
Multisystem inflammatory syndrome in adults associated with COVID-19 |
|
|
Bolieva L., Malyavin A., Aidarova N., Byazrova S.
|
| Volume 7, Nº 10 (2021) |
Mucins and carbocisteine: respiratory protection |
|
|
Babak S., Gorbunova M., Malyavin A.
|
| Volume 9, Nº 3 (2023) |
Patient with hyperuricemia and chronic kidney disease is at the doctor: Peculiarities of curation in accordance with Russian recommendations |
|
|
Maksudova A., Khalfina T., Almukhametova A.
|
| Volume 9, Nº 10 (2023) |
Mineral density bone tissue disorder in case of inflammatory bowel diseases (literature review) |
|
|
Abdulganieva D., Kupkenova L., Yangurazova A., Myasoutova E.
|
| Volume 8, Nº 1 (2022) |
Smell and taste impairment in young adults with COVID-19 |
|
|
Izmozherova N., Popov A., Shambatov M., Baksheev I.
|
| Volume 11, Nº 6 (2025) |
Impairment of renal magnesium transportation in patients with hyperuricemic chronic tubulointerstitial nephritis while using nonsteroidal anti-inflammatory drugs |
|
|
Voronina N., Bulkina V., Lemeshchenko O., Zhmerenetsky K.
|
| Nº 3 (2018) |
Disturbances of water and electrolyte homeostasis as a predictor of an unfavorable long-term prognosis in patients hospitalized for decompensated CHF |
|
|
Fazulina C., Fomin V., Meshalkina V.
|
| Volume 9, Nº 6 (2023) |
Hereditary gout in a young woman with allopurinol intolerance |
|
|
Garanin A., Lebedev P., Paranina E.
|
| Nº 2 (2015) |
National guidelines for the diagnosis and treatment of acid-related and associated with Helicobacter pylori diseases (V Moscow agreement) |
|
|
- -.
|
| Volume 8, Nº 4 (2022) |
Our contemporary person: to the 80th anniversary of the birth of Yu.B. BELOUSOV |
|
|
ROMAShEVSKAYa E., KOKORIN V.
|
| Nº S1 (2022) |
NDST kak faktor riska razvitiya psikhovegetativnykh rasstroystv i khronicheskoy ishemii golovnogo mozga u lits molodogo vozrasta |
|
|
Mal'tseva I., Lomakina N.
|
| Volume 7, Nº 7 (2021) |
Non-alcoholic fatty liver disease and atherosclerosis: common mechanisms of development and progression |
|
|
Kuznetsova A., Genkel V., Dolgushina A., Shaposhnik I., Olevskaya E., Selyanina A., Khusainova G.
|
| Nº S1 (2022) |
Nealkogol'naya zhirovaya bolezn' pecheni i metabolicheskiy sindrom u lits molodogo vozrasta |
|
|
Pankova E.
|
| Volume 7, Nº 7 (2021) |
Non-alcoholic fatty liver disease in adults: clinic, diagnostics, treatment (clinical guidelines for therapists, third version) |
|
|
Lazebnik L.
|
| Nº 2 (2016) |
Nonalcoholic fatty liver disease: clinic, diagnostics, treatment |
|
|
- -.
|
| Nº 3 (2017) |
Nonalcoholic fatty liver disease: clinic, diagnostics, treatment (guidelines for the specialists on internal medicine, 2nd version) |
|
|
Lazebnik L., Radchenko V., Golovanova Y., Zvenigorodskaya L., Konev Y., Seliverstov P., Sitkin S., Tkachenko Y., Avalueva Y., Ailamazyan E., Vlasov N., Grinevich V., Kornienko Y., Novikov V., Khoroshinina L., Zhestkova N., Oreshko L., Dudanova O., Dobritsa V., Turieva L., Tirikova O., Kozlova N., Yeliseev S., Gumerov R., Ventsak Y., Aleshina Y., Gurova M., Goryacheva L.
|
| Volume 8, Nº 5 (2022) |
Nebulized budesonide in asthma exacerbations: rules of therapy in the COVID-19 era |
|
|
Babak S., Gorbunova M., Goruleva E., Malyavin A.
|
| Volume 8, Nº 3 (2022) |
Neurological aspects of the postcovide syndrome |
|
|
Kamchatnov P., Khanmurzayeva S., Chugunov A., Khanmurzayeva N.
|
| Volume 8, Nº 1 (2022) |
Neurological manifestations of post-covid syndrome |
|
|
Zakharov V., Gromova D.
|
| Volume 8, Nº 7 (2022) |
Non-invasive assessment of liver abnormalities in patients with psoriatic arthritis |
|
|
Mukhametshina E., Kirillova E., Fairushina I., Abdulganieva D.
|
| Volume 9, Nº 5 (2023) |
Infraptellar nerve neuropathy as a cause of chronic pain in knee joint area |
|
|
Lyalina V., Skripnichenko E., Borisovskaya S., Oknin V., Migachev S., Plieva Z., Lazko F., Baskov A., Belykh Y., Nikitin I.
|
| Volume 9, Nº 10 (2023) |
Neurorehabilitation after a stroke: what a therapist should know |
|
|
Shishkova V., Shishkov V.
|
| Nº 4 (2016) |
Some aspects of pathogenesis and prevention of sudden cardiac death in patients with chronic obstructive pulmonary disease |
|
|
Karoli N., Rebrov A.
|
| Nº S1 (2022) |
Nekotorye aspekty patogeneza immunovospalitel'nykh zabolevaniy |
|
|
Shilkina N., Dryazhenkova I., Yunonin I., Chetvertakova Z.
|
| Nº 4S (2022): Supplement |
Various manifestation of kidney damage with in COVID-19 |
|
|
Bala A.
|
| Nº 4S (2022): Supplement |
Some clinical features of the combination of diabetes mellitus and COVID-19 |
|
|
Elizarova I., Chernykh T., Zoloyedov V.
|
| Nº S1 (2022) |
Nemedikamentoznoe vosstanovlenie ritma stula s pomoshch'yu natural'noy mineral'noy vody u molodykh i pozhilykh patsientov |
|
|
Shemerovskiy K., Kantemirova R., Seliverstov P., Vasil'ev V.
|
| Volume 8, Nº 6 (2022) |
Non-drug methods of treatment in pulmonology |
|
|
Prozorova G., Fateeva O., Tribuntseva L., Kozhevnikova S., Olysheva I.
|
| Nº 2 (2016) |
UNUSUAL CARDIAC COMPLICATIONS OF VULVAR CANCER: INTRACARDIAC METASTASES AND NON-INFECTIVE THROMBOTIC ENDOCARDITIS |
|
|
KARAMYSHEV D.
|
| Volume 10, Nº 4 (2024) |
Unsolved mysteries of “broken heart” syndrome |
|
|
Kozlova A., Kokorin V.
|
| Volume 10, Nº 1 (2024) |
Nonsteroidal anti-inflammatory drugs in therapeutical practice |
|
|
Karateev A.
|
| Volume 9, Nº 5 (2023) |
Non-steroid anti-inflammatory drugs in musculoskeletal pain syndrome therapy: Aspects of their effective and safe use |
|
|
Dronova Y., Mubarakshina O., Chernov S.
|
| Nº S1 (2022) |
Nizkaya predtestovaya veroyatnost' ishemicheskoy bolezni serdtsa: analiz faktorov riska |
|
|
Roytberg G., Slastnikova I., Davydova A.
|
| Nº S1 (2022) |
Novaya koronavirusnaya infektsiya COVID-19, oslozhnennaya razvitiem bystroprogressiruyushchego glomerulonefrita s obrazovaniem antitel k glomerulyarnoy bazal'noy membrane |
|
|
Navaznov V., Tasoeva E., Karpova S., Pavlov A., Prokhorchik A., Gulyaev N., Baksheev V.
|
| Volume 8, Nº 8 (2022) |
Novel coronavirus infection COVID-19: nutritional support from the beginning of the disease to rehabilitation |
|
|
Sirota A., Pasechnik I., Novikova T.
|
| Nº 1 (2018) |
New strategy of mucolytic therapy in modern medical practice |
|
|
Babak S., Gorbunova M., Malyavin A.
|
| Nº 5 (2018) |
News of clinical recommendations on diagnostics and treatment of subclinical hypothyroidism in pregnant women |
|
|
Demidova T., Balutina O., Gritzkevich E.
|
| Volume 9, Nº 4 (2023) |
New opportunities for chronic heart failure patients’ treatment: focus at dapagliflosin |
|
|
Malimon V., Kokorin V.
|
| Volume 8, Nº 2 (2022) |
NEW POSSIBILITIES OF LOCAL INJECTION THERAPY IN COMPLEX TREATMENT OF SKELETAL AND MUSCULAR PAIN |
|
|
NESTERENKO V., KARATEEV A.
|
| Nº 3 (2018) |
New possibilities for personalizing prognosis in patients with nonvalvular atrial fibrillation |
|
|
Agibova N., Boeva O.
|
| Nº 1 (2018) |
New possibilities of artificial intelligence method applications for to simulate the occurrence and development of diseases and optimize their prevention and treatment |
|
|
Yasnitsky L., Dumler A., Cherepanov F.
|
| Nº 7-8 (2018) |
New possibilities of uratedecreasing therapy in patients with arthrolithiasis |
|
|
Petrova M., Musiichuk M., Inamova O., Mazurov V.
|
| Nº 3 (2015) |
NEW POSSIBILITIES OF PHARMACOLOGICAL CARDIOVERSION OF NEWLY DEVELOPED PAROXYSM OF ATRIAL FIBRILLATION |
|
|
Cheltsov V., Guschina Y., Illarionova T., Korovyakova E., Martynov A.
|
| Volume 10, Nº 9 (2024) |
New horizons in managing dyslipidemia – a risk factor for cardiovascular diseases |
|
|
Usanova A., Novikova E., Sergutova N., Kuzma F., Vasilkova A.
|
| Nº 2 (2017) |
New data on safety of NSAIDs: concept of the «class-specific» high cardiovascular risk of selective COX-2 inhibitors got out of date |
|
|
Karateev A., Nasonov Y., Novikova D.
|
| Nº 4S (2022): Supplement |
New diagnostic capabilities of the 6-minute walk test in COPD patients |
|
|
Babkin A.
|
| Volume 8, Nº 5 (2022) |
New criteria for long-term CPAP therapy adherence in obstructive sleep apnea syndrome and arterial hypertension patients |
|
|
Ovchinnikov Y., Mostovoy L., Zaitsev A.
|
| Volume 7, Nº 6 (2021) |
New perspectives and real possibilities in the treatment of patients with heart failure |
|
|
Shulkina S., Kokorin V.
|
| Nº S1 (2022) |
Novye podkhody k optimizatsii terapii professional'noy bronkhial'noy astmy s fiksirovannoy bronkhial'noy obstruktsiey |
|
|
Artemova L., Rumyantseva O., Petrykina M.
|
| Nº 4S (2022): Supplement |
New ways for diagnostics of non-specific ulcerative colitis |
|
|
Lagutina S., Zuikova A., Dobrynina I., Kotova Y.
|
| Volume 10, Nº 8 (2024) |
New therapeutic opportunities of gastroprotection in cardiology |
|
|
Golendyaeva P., Livzan M., Korennova O., Gaus O., Podolnaya S., Shkirinets A., Shukil L., Maltsev S.
|
| Nº 1 (2016) |
A NEW LOOK AT THE EFFECTS OF METFORMIN |
|
|
Poluboyarinova I., Fadeev V.
|
| Nº 3 (2017) |
Nolodotak (flupirtine) in treatment of patients with dorsopathy |
|
|
Kamchatnov P., Khanmurzaeva N., Khanmurzaeva S.
|
| Volume 10, Nº 3 (2024) |
NSAIDs gastropathies in clinician’s practice |
|
|
Bakulin I., Avalueva E., Bakulina N., Serkova M., Berest D., Pavlova E.
|
| Nº 1 (2016) |
SHOULD WE TREAT GRADE 1 HYPERTENSION? |
|
|
Aksenov V., Vlasov V.
|
| Nº S1 (2022) |
O vzaimosvyazi klinicheskikh proyavleniy postinfektsionnogo glomerulonefrita s funtsional'nym sostoyaniem shchitovidnoy zhelezy |
|
|
Kudryashov S.
|
| Nº 4 (2015) |
THERAPEUTIC APPROACHES TO THE PROBLEM of diabetic angiopathy in diabetes MELLITUS TYPE 2: FOCUS ON OPPORTUNITIES OF TRICOR |
|
|
Ruyatkina L., Ruyatkin D., Zemlyanukhina S.
|
| Nº 1 (2017) |
On the pharmacological interactions of antibiotics magnesium and on the magnesium deficiency ar as a result of antibiotic treatment |
|
|
Gromova O., Torshin I., Moiseev V., Sorokina M.
|
| Nº 1 (2018) |
About fundamental and clinical aspects of magnesium and ribolavine synergic action in therapeutic practice |
|
|
Gromova O., Torshin I., Kobalava Z., Sorokina M.
|
| Nº 1 (2017) |
The use of zinc and vitamin С for the prevention and adjuvant therapy of acute respiratory diseases |
|
|
Gromova O., Torshin I., Moiseev V., Sorokina M., Limanova O.
|
| Volume 8, Nº 8 (2022) |
Review of international clinical guidelines for diagnosis and treatment of late androgen deficiency in male patients |
|
|
Skuridina D., Demidova T.
|
| Volume 7, Nº 9 (2021) |
Review of current opportunities in cardiovascular risks management in patients with type 2 diabetes mellitus |
|
|
Demidova T., Mkrtamyan A.
|
| Nº 4S (2022): Supplement |
The validity of prescribing drug prevention of gastroduodenal bleeding in patients with chronic ischemic heart disease |
|
|
Dronova Y., Belesikova V.
|
| Nº 2 (2016) |
EXACERBATION OF CHRONIC CHOLECYSTITIS UNDER THE MASK OF PAIN FORM OF OSTEOCHONDROSIS OF THE THORACIC SPINE |
|
|
ROITBERG G., DOROSH J.
|
| Nº 7 (2017) |
General aspects of pharmacigenetics and their importance in the clinical practice |
|
|
Leonova M.
|
| Volume 7, Nº 7 (2021) |
General patterns and regional features of epidemiology and the course of ulcerative colitis in the Rostov region |
|
|
Tkachev A., Belovolova R., Mkrtchyan L., Mazovka K.
|
| Volume 7, Nº 8 (2021) |
Dyspnoea and respiratory mechanics disturbances in obesity patients |
|
|
Kucherenko N., Bebekh A., Umarova I., Gorelov A.
|
| 701 - 800 de 1593 resultados |
<< < 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 > >> |
